EMA guidelines highlight changes to IMPs triggering notification to regulators

Regulatory NewsRegulatory NewsChemistry, Manufacturing and Controls (CMC)Clinical TrialsComplianceEuropePharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy